Skip to main content

stock

ANIX · Anixa Biosciences Inc

What Anixa Biosciences Inc reports to the SEC, read from its filings.

Open in the app

Price

The live ANIX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ANIX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
34,763,802 as of 2026-09-09 (XBRL frame CY2026Q3I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-71.7%
ROA
-68.9%

Health

Current ratio
8.5x
Debt/equity
—

Deep value

NCAV
$13.04M
NCAV per share
$0.38
Price/NCAV
Locked
NNWC
-$475,000
NNWC per share
-$0.01
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-07-31; balance sheet at 2026-07-31.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-07-31——Gross profit: unreported by this company.-$2.74M-$2.61M
10-Q filed 2026-09-09
2026-04-30——Gross profit: unreported by this company.-$2.65M-$2.52M
10-Q filed 2026-06-10
2026-01-31——Gross profit: unreported by this company.-$2.72M-$2.56M
10-Q filed 2026-03-09
2025-10-31——Gross profit: unreported by this company.-$2.88M-$2.69M
10-K filed 2026-01-12
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-07-31——Gross profit: unreported by this company.-$2.44M-$2.26M
10-Q filed 2026-09-09
2025-04-30——Gross profit: unreported by this company.-$3.00M-$2.79M
10-Q filed 2026-06-10
2025-01-31——Gross profit: unreported by this company.-$3.39M-$3.18M
10-Q filed 2026-03-09
2024-10-31——Gross profit: unreported by this company.-$3.16M-$2.88M
10-K filed 2026-01-12
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assets
$15.07M
Equity
$14.47M

Balance as of 2026-07-31.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-10-31—-$11.70M-$10.93M—
2024-10-31$210,000-$13.83M-$12.55M—
2023-10-31$210,000-$11.01M-$9.81M—
2022-10-31—-$13.88M-$13.60M—
2021-10-31$512,000-$13.14M-$12.95M—
2020-10-31—-$9.98M-$10.02M-$6.19M
2019-10-31$250,000-$11.89M-$11.65M-$4.92M
2018-10-31$1.11M-$14.29M-$14.00M-$4.31M
2017-10-31$362,500-$6.08M-$5.01M-$3.83M
2016-10-31$300,000-$4.51M-$5.02M-$3.53M

Company filings

events

  • Shareholder vote results, Regulation FD disclosure

    Shareholder vote resultsRegulation FD disclosure
    Mar 118-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Feb 98-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Dec 118-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Catelani Michael

    President, COO, & CFO

    Buy$15,620

    Sep 30, 10:25 AM ET

  • KUMAR AMIT

    Chief Executive Officer, Director

    Buy$19,460

    Sep 28, 8:45 AM ET

  • Baskies Arnold M

    Director

    Buy$13,800

    Sep 28, 8:30 AM ET

  • Titterton Lewis H jr

    Director

    Buy$131,907

    Sep 25, 8:39 AM ET

  • KUMAR AMIT

    Chief Executive Officer, Director

    Buy$8,250

    Sep 14, 9:45 AM ET

All insider trades for ANIX

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ANIX, and the market events around them.

Sign in to see this

Board

The ANIX board could not be loaded.

Retry the ANIX board

nakagai

Signals on ANIX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ANIX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Anixa Biosciences Inc (ANIX): SEC filings, financials and insider trades · Nakagai